NEW YORK, Sept. 23, 2016 – Alzheimer’s, cancer and other incurable diseases such as Parkinson’s and dementia can be contagious, according to researchers at the Human Microbiology Institute, who have published research linking the diseases to newly discovered bacterial viruses.
NEW YORK, June 7, 2016 /PRNewswire/ — Researchers at the Human Microbiology Institute (HMI) have uncovered a potential new Alzheimer’s treatment that significantly reversed the late-stage effects of the debilitating neurodegenerative disease.
NEW YORK (May 27, 2016) – Human Microbiology Institute, delighted to present that its scientific core has been in the background of groundbreaking study for the compassionate use study of dementia in end-stage Alzheimer’s disease.
NEW YORK (May 5, 2016) – Human Microbiology Institute is delighted to announce that its scientific core played a primary role in the groundbreaking study for the treatment of dementia in end-stage Alzheimer’s disease.
NEW YORK (April 30, 2016) – Human Microbiology Institute reports the complete genome sequence of novel species Bacillus sp VT-712 isolated from the intestine of a patient with duodenal cancer.
NEW YORK (April 26, 2016) – Human Microbiology Institute a not-for-profit scientific research organization, today announced that George Tetz and Victor Tetz will present data for the research study “The Novel Species Paenibacillus sp. VT-400 as a Potentially Pathogenic Spore-Forming Bacteria in the Oral Cavity of Patients with Hematological Malignancies” at the ASM Microbe 2016 Conference (June 16–20, 2016, Boston, MA).